Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease

Completed · Phase 2

Conditions studied: Parkinson's Disease

In brief

The purpose of this study is to determine whether Fipamezole is effective in the treatment of levodopa-induced dyskinesia in advanced Parkinson's disease.

Key facts

Study ID
NCT00559871
Run by
Juvantia Pharma Ltd
People needed
180
Starts
2007-10-01
Expected to finish
2009-05-01
Last updated by the study team
2009-06-03

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.